Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant

• Main Authors: Nicolò Reccardini (Author), Maria Chernovsky (Author), Francesco Salton (Author), Paola Confalonieri (Author), Lucrezia Mondini (Author), Mariangela Barbieri (Author), Antonio Romallo (Author), Marta Maggisano (Author), Chiara Torregiani (Author), Pietro Geri (Author), Michael Hughes (Author), Corrado Campochiaro (Author), Marco Confalonieri (Author), Angelo Scarda (Author), Umberto Zuccon (Author), Barbara Ruaro (Author)
• Format: Book
• Published: MDPI AG, 2024-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Idiopathic pulmonary fibrosis (IPF) is a rare and progressive interstitial lung disease characterized by irreversible distortion of lung architecture and subsequent loss of pulmonary function. Pirfenidone is an antifibrotic agent associated with increased progression-free survival and overall surviv...